Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Primary hyperoxaluria Type 1 is a rare autosomal recessive inborn error of glyoxylate metabolism, caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase. The disorder results in overproduction and excessive urinary excretion of oxalate, causing recurrent urolithiasis and nephrocalcinosis. As glomerular filtration rate declines due to progressive renal involvement, oxalate accumulates leading to systemic oxalosis. The diagnosis is based on clinical and sonographic findings, urine oxalate assessment, enzymology and/or DNA analysis. Early initiation of conservative treatment (high fluid intake, pyridoxine, inhibitors of calcium oxalate crystallization) aims at maintaining renal function. In chronic kidney disease Stages 4 and 5, the best outcomes to date were achieved with combined liver-kidney transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines on Urolithiasis<footref rid="foot01">1</footref>
Tiselius, H. G., Ackermann, D., Alken, P., Buck, C., Conort, P., & Gallucci, M. (2001) · European Urology · doi:10.1159/000049803 · Cited by 1,140
Borghi, L., Meschi, T., Amato, F., Briganti, A., Novarini, A., & Giannini, A. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66321-3 · Cited by 925
Contribution of dietary oxalate to urinary oxalate excretion
Holmes, R. P., Goodman, H. O., & Assimos, D. G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00488.x · Cited by 499
Hoppe, B., Beck, B. B., & Milliner, D. S. (2009) · Kidney International · doi:10.1038/ki.2009.32 · Cited by 375
Self-citationPeroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I
Danpure, C. J., & Jennings, P. R. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80563-4 · Cited by 352
Self-citationPurdue, P. E., Takada, Y., & Danpure, C. J. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.2341 · Cited by 237
Self-citationMutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Belostotsky, R., Seboun, E., Idelson, G. H., Milliner, D. S., Becker-Cohen, R., Rinat, C., Monico, C. G., Feinstein, S., Ben-Shalom, E., Magen, D., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.023 · Cited by 233
LEUMANN, E., & HOPPE, B. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1291986 · Cited by 228
Self-citationOxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
Hoppe, B., Beck, B., Gatter, N., von Unruh, G., Tischer, A., Hesse, A., Laube, N., Kaul, P., & Sidhu, H. (2006) · Kidney International · doi:10.1038/sj.ki.5001707 · Cited by 215
Self-citationEpidemiology of primary hyperoxaluria type 1
Cochat, P., Deloraine, A., Rotily, M., Olive, F., Liponski, I., Deries, N., & Pediatrique, O. B. O. T. S. D. N. A. T. S. D. N. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp8.3 · Cited by 186
Self-citationMilliner, D. S., Eickholt, J. T., Bergstralh, E. J., Wilson, D. M., & Smith, L. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312304 · Cited by 182
Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome
van Woerden, C. S. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.273 · Cited by 180
Self-citationCEREBRAL CONSUMPTION OF GLUCOSE - REPLY
Warrell, D. A. (1989) · The Lancet · Cited by 180
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene
Williams, E. L., Acquaviva, C., Amoroso, A., Chevalier, F., Coulter-Mackie, M., Monico, C. G., Giachino, D., Owen, T., Robbiano, A., Salido, E., et al. (2009) · Human Mutation · doi:10.1002/humu.21021 · Cited by 175
Self-citationCharacteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy
Harambat, J., van Stralen, K. J., Espinosa, L., Groothoff, J. W., Hulton, S., Čerkauskienė, R., Schaefer, F. S., Verrina, E. E., Jager, K. J., & Cochat, P. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07430711 · Cited by 154
Self-citationPrimary hyperoxaluria type 1: still challenging!
Cochat, P., Liutkus, A., Fargue, S., Basmaison, O., Ranchin, B., & Rolland, M.-O. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0124-4 · Cited by 146
Self-citationEfficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
Höppe, B., Groothoff, J. W., Hulton, S., Cochat, P., Niaudet, P., Kemper, M. J., Deschênes, G., Unwin, R. J., & Milliner, D. S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr107 · Cited by 146
Self-citationManagement of primary hyperoxaluria: efficacy of oral citrate administration
Leumann, E., Höppe, B., & Neuhaus, T. J. (1993) · Pediatric Nephrology · doi:10.1007/bf00864405 · Cited by 130
Treatment of Renal Stones by Extracorporeal Shockwave Lithotripsy
Rassweiler, J. J., Renner, C., Chaussy, C., & roff, S. T. U. (2001) · European Urology · doi:10.1159/000052435 · Cited by 128
Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure
Höppe, B., Graf, D., Offner, G., Latta, K., Byrd, D. J., Michalk, D. V., & Brodehl, J. (1996) · Pediatric Nephrology · doi:10.1007/s004670050145 · Cited by 101
Canavese, C., Petrarulo, M., Massarenti, P., Berutti, S., Fenoglio, R., Pauletto, D., Lanfranco, G., Bergamo, D., Sandri, L., & Marangella, M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.10.025 · Cited by 97
Self-citationWatts, R. W. E., Veall, N., & Purkiss, P. (1984) · Clinical Science · doi:10.1042/cs0660591 · Cited by 80
Primary Hyperoxaluria – The German Experience
Höppe, B., Latta, K., von Schnakenburg, C., & Kemper, M. J. (2005) · American Journal of Nephrology · doi:10.1159/000086358 · Cited by 71
Self-citationEnd-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome
Kamoun, A., & Lakhoua, R. (1996) · Pediatric Nephrology · doi:10.1007/s004670050143 · Cited by 70
Oxalate Balance Studies in Patients on Hemodialysis for Type I Primary Hyperoxaluria
Marangella, M., Petrarulo, M., Cosseddu, D., Vitale, C., & Linari, F. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80833-x · Cited by 67
Self-citationPrimary hyperoxaluria type 1: strategy for organ transplantation
Cochat, P., Fargue, S., & Harambat, J. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32833e35f5 · Cited by 59
Self-citationSikora, P., Unruh, G. E. V., Beck, B. B., Feldkötter, M., Zajączkowska, M., Hesse, A., & Höppe, B. (2008) · Kidney International · doi:10.1038/ki.2008.63 · Cited by 57
de Lorenzo, V., Alvarez, A., Torres, A., Torregrosa, V., Hernández, D., & SALIDO, E. C. (2006) · Kidney International · doi:10.1038/sj.ki.5001758 · Cited by 56
Self-citationUrinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?
Höppe, B., Hesse, A., Brömme, S., Rietschel, E., & Michalk, D. V. (1998) · Pediatric Nephrology · doi:10.1007/s004670050452 · Cited by 51
Plasma and Urine Glycolate Assays for Differentiating the Hyperoxaluria Syndromes
Marangella, M., Petrarulo, M., Vitale, C., Cosseddu, D., & Linari, F. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36796-4 · Cited by 49
Self-citationLIVER TRANSPLANTATION IN PRIMARY HYPEROXALURIA TYPE 1
Cochat, P., Faure, J. L., Divry, P., Danpure, C., Descos, B., Wright, C. C., Takvorian, P., & Floret, D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92423-9 · Cited by 47
Self-citationEffects of different calcineurin inhibitors on sex hormone levels in transplanted male patients
Kantarcı, G., Şahin, S., Uras, A. R., & Ergin, H. (2004) · Transplantation Proceedings · doi:10.1016/j.transproceed.2003.11.017 · Cited by 47
Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1
Yamauchi, T., Quillard, M., TAKAHASHI, S. Y., & Man, N. K. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.12.2407 · Cited by 46
Cited by
Cochat, P., & Rumsby, G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1301564 · Cited by 586
Self-citationSquires, R. H., Ng, V., Romero, R., Ekong, U., Hardikar, W., Emre, S., & Mazariegos, G. V. (2014) · Hepatology · doi:10.1002/hep.27191 · Cited by 254
The physiological functions of human peroxisomes
Wanders, R. J. A., Baes, M., Ribeiro, D., Ferdinandusse, S., & Waterham, H. R. (2023) · Physiological Reviews · doi:10.1152/physrev.00051.2021 · Cited by 228
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Wang, X., Danese, D., Brown, T., Baldwin, J., Sajeev, G., Cook, E. E., Wang, Y., Xu, C., Yang, H., & Moritz, M. L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.703305 · Cited by 13
Metadata
- Authors
- Cochat, P., Hulton, S.-A., Acquaviva, C., Danpure, C. J., Daudon, M., De Marchi, M., Fargue, S., Groothoff, J., Harambat, J., Hoppe, B., Jamieson, N. V., Kemper, M. J., Mandrile, G., Marangella, M., Picca, S., Rumsby, G., Salido, E., Straub, M., van Woerden, C. S., & (), O. B. O. O.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-30
- Volume
- 27
- Issue
- 5
- Pages
- 1729-1736
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2106951882
- Cited by
- 335
- References
- 33
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.